title |
Antiinflammatory activity in C57BL/6J mouse model of DSS-induced colon inflammation assessed as reduction of colon MIG level at 2.1 mg/kg/day, po for 21 days followed by compound dosing for 8 days co-administered with DSS followed by 2.1 mg/kg/day, po dosing for 6 days in absence of DSS measured on days 29 and day 35 by chemiluminescence assay |